Open-Label, Phase 1 Study to Evaluate Duration of Severe Neutropenia After Same-Day Dosing of Eflapegrastim in Patients With Breast-Cancer
Spectrum Pharmaceuticals, Inc
Spectrum Pharmaceuticals, Inc
National Cancer Institute (NCI)
EVIVE Biotechnology
Canadian Cancer Trials Group
National Institutes of Health Clinical Center (CC)
Wake Forest University Health Sciences
Tianjin SinoBiotech Ltd.
Enzychem Lifesciences Corporation
Enzychem Lifesciences Corporation
UNC Lineberger Comprehensive Cancer Center
Tianjin SinoBiotech Ltd.
GOG Foundation
Children's Oncology Group
National Cancer Institute (NCI)
Mayo Clinic
National Institutes of Health Clinical Center (CC)